Zepto® has been demonstrated in a FDA clinical trial to be safe and effective.  No change in corneal incision size was observed after Zepto use in 70% of cases, and a mean enlargement of 30 micron was encountered in 30% of cases.  No differences in ocular condition have been observed after Zepto use compared to CCC, with a peak temperature increase of 1-2°C for a fraction of a second.

View Miyake-Apple Imaging of Zonular Tissue During Zepto Use

View Temperature Testing and Data Sheet

Download Peer Reviewed Publication of Zepto Capsulotomy Strength Testing

Download Peer Reviewed Publication with Zepto Product Performance Review

NEWS

10 Sep Healio News: Automated Zepto Capsulotomy Has Advantages in Premium Procedures The Zepto capsulotomy system offers surgeons the opportunity to ... read more ›
30 Aug Zepto Surgical Case Narrations by Dr. Ike Ahmed Dr. Ike Ahmed, of the University of Toronto and the Kensington Eye ... read more ›
07 Aug Mynosys Cellular Devices, Inc. Joins AdvaMed Mynosys Cellular Devices, the creators of the Zepto® precision ... read more ›

FEATURED VIDEO